Isosorbide mononitrate sustained-release tablets are a formulation of the medication used to prevent and relieve chest pain (angina) in individuals with coronary artery disease. These tablets are designed to provide a slow and controlled release of the medication, allowing for once-daily dosing in most cases.

The global market for Isosorbide Mononitrate Sustained-release Tablet was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Isosorbide Mononitrate Sustained-release Tablet, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Isosorbide Mononitrate Sustained-release Tablet by region & country, by Type, and by Application.

The Isosorbide Mononitrate Sustained-release Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isosorbide Mononitrate Sustained-release Tablet.

Market Segmentation

Scope of Isosorbide Mononitrate Sustained-release Tablet - Market Report

Report Metric	Details
Report Name	Isosorbide Mononitrate Sustained-release Tablet - Market
CAGR	5%
Segment by Type:	40mg 50mg Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mayo Clinic, Lotus Pharmaceuticals, Recipeharm, Hefei Cosource Pharmacetical, Lukang Jituan Saite Yaoye, Lepu Pharmaceuticals, Keyuan Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Isosorbide Mononitrate Sustained-release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Isosorbide Mononitrate Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Isosorbide Mononitrate Sustained-release Tablet in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Isosorbide Mononitrate Sustained-release Tablet - Market report?

Ans: The main players in the Isosorbide Mononitrate Sustained-release Tablet - Market are Mayo Clinic, Lotus Pharmaceuticals, Recipeharm, Hefei Cosource Pharmacetical, Lukang Jituan Saite Yaoye, Lepu Pharmaceuticals, Keyuan Pharmaceutical

What are the Application segmentation covered in the Isosorbide Mononitrate Sustained-release Tablet - Market report?

Ans: The Applications covered in the Isosorbide Mononitrate Sustained-release Tablet - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Isosorbide Mononitrate Sustained-release Tablet - Market report?

Ans: The Types covered in the Isosorbide Mononitrate Sustained-release Tablet - Market report are 40mg, 50mg, Other

1 Market Overview

1.1 Isosorbide Mononitrate Sustained-release Tablet Product Introduction

1.2 Global Isosorbide Mononitrate Sustained-release Tablet Market Size Forecast

1.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030)

1.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume (2019-2030)

1.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Price (2019-2030)

1.3 Isosorbide Mononitrate Sustained-release Tablet Market Trends & Drivers

1.3.1 Isosorbide Mononitrate Sustained-release Tablet Industry Trends

1.3.2 Isosorbide Mononitrate Sustained-release Tablet Market Drivers & Opportunity

1.3.3 Isosorbide Mononitrate Sustained-release Tablet Market Challenges

1.3.4 Isosorbide Mononitrate Sustained-release Tablet Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Isosorbide Mononitrate Sustained-release Tablet Players Revenue Ranking (2023)

2.2 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Company (2019-2024)

2.3 Global Isosorbide Mononitrate Sustained-release Tablet Players Sales Volume Ranking (2023)

2.4 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Company Players (2019-2024)

2.5 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Company (2019-2024)

2.6 Key Manufacturers Isosorbide Mononitrate Sustained-release Tablet Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Isosorbide Mononitrate Sustained-release Tablet Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Isosorbide Mononitrate Sustained-release Tablet

2.9 Isosorbide Mononitrate Sustained-release Tablet Market Competitive Analysis

2.9.1 Isosorbide Mononitrate Sustained-release Tablet Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Isosorbide Mononitrate Sustained-release Tablet Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isosorbide Mononitrate Sustained-release Tablet as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 40mg

3.1.2 50mg

3.1.3 Other

3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type

3.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value, by Type (2019-2030)

3.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value, by Type (%) (2019-2030)

3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type

3.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume, by Type (2019-2030)

3.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume, by Type (%) (2019-2030)

3.4 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Other

4.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application

4.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value, by Application (2019-2030)

4.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value, by Application (%) (2019-2030)

4.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application

4.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume, by Application (2019-2030)

4.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume, by Application (%) (2019-2030)

4.4 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region

5.1.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2019-2024)

5.1.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2025-2030)

5.1.4 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (%), (2019-2030)

5.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region

5.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (2019-2024)

5.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (2025-2030)

5.2.4 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (%), (2019-2030)

5.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

5.4.2 North America Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

5.5.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

5.6.2 Asia Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

5.7.2 South America Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

5.8.2 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value

6.2.1 Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.2.2 Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.3.2 United States Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.4.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.5.2 China Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.5.3 China Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.6.2 Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.7.2 South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.8.2 Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019-2030

6.9.2 India Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

6.9.3 India Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Mayo Clinic

7.1.1 Mayo Clinic Company Information

7.1.2 Mayo Clinic Introduction and Business Overview

7.1.3 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.1.5 Mayo Clinic Recent Development

7.2 Lotus Pharmaceuticals

7.2.1 Lotus Pharmaceuticals Company Information

7.2.2 Lotus Pharmaceuticals Introduction and Business Overview

7.2.3 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.2.5 Lotus Pharmaceuticals Recent Development

7.3 Recipeharm

7.3.1 Recipeharm Company Information

7.3.2 Recipeharm Introduction and Business Overview

7.3.3 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.3.5 Recipeharm Recent Development

7.4 Hefei Cosource Pharmacetical

7.4.1 Hefei Cosource Pharmacetical Company Information

7.4.2 Hefei Cosource Pharmacetical Introduction and Business Overview

7.4.3 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.4.5 Hefei Cosource Pharmacetical Recent Development

7.5 Lukang Jituan Saite Yaoye

7.5.1 Lukang Jituan Saite Yaoye Company Information

7.5.2 Lukang Jituan Saite Yaoye Introduction and Business Overview

7.5.3 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.5.5 Lukang Jituan Saite Yaoye Recent Development

7.6 Lepu Pharmaceuticals

7.6.1 Lepu Pharmaceuticals Company Information

7.6.2 Lepu Pharmaceuticals Introduction and Business Overview

7.6.3 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.6.5 Lepu Pharmaceuticals Recent Development

7.7 Keyuan Pharmaceutical

7.7.1 Keyuan Pharmaceutical Company Information

7.7.2 Keyuan Pharmaceutical Introduction and Business Overview

7.7.3 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product Offerings

7.7.5 Keyuan Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Isosorbide Mononitrate Sustained-release Tablet Industrial Chain

8.2 Isosorbide Mononitrate Sustained-release Tablet Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Isosorbide Mononitrate Sustained-release Tablet Sales Model

8.5.2 Sales Channel

8.5.3 Isosorbide Mononitrate Sustained-release Tablet Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Lotus Pharmaceuticals

Recipeharm

Lukang Jituan Saite Yaoye

Lepu Pharmaceuticals

Keyuan Pharmaceutical

Hefei Cosource Pharmacetical

Mayo Clinic

List of Tables

Table 1. Isosorbide Mononitrate Sustained-release Tablet Market Trends

Table 2. Isosorbide Mononitrate Sustained-release Tablet Market Drivers & Opportunity

Table 3. Isosorbide Mononitrate Sustained-release Tablet Market Challenges

Table 4. Isosorbide Mononitrate Sustained-release Tablet Market Restraints

Table 5. Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Isosorbide Mononitrate Sustained-release Tablet Revenue Market Share by Company (2019-2024)

Table 7. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Isosorbide Mononitrate Sustained-release Tablet Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Isosorbide Mononitrate Sustained-release Tablet Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Isosorbide Mononitrate Sustained-release Tablet Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Isosorbide Mononitrate Sustained-release Tablet

Table 13. Global Isosorbide Mononitrate Sustained-release Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isosorbide Mononitrate Sustained-release Tablet as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Isosorbide Mononitrate Sustained-release Tablet Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Isosorbide Mononitrate Sustained-release Tablet Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Isosorbide Mononitrate Sustained-release Tablet Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Isosorbide Mononitrate Sustained-release Tablet Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2019-2024) & (%)

Table 44. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2025-2030) & (%)

Table 45. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (2019-2024) & (%)

Table 49. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Region (2025-2030) & (%)

Table 50. Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Volume, (2025-2030) & (K Units)

Table 57. Mayo Clinic Company Information

Table 58. Mayo Clinic Introduction and Business Overview

Table 59. Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 61. Mayo Clinic Recent Development

Table 62. Lotus Pharmaceuticals Company Information

Table 63. Lotus Pharmaceuticals Introduction and Business Overview

Table 64. Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 66. Lotus Pharmaceuticals Recent Development

Table 67. Recipeharm Company Information

Table 68. Recipeharm Introduction and Business Overview

Table 69. Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 71. Recipeharm Recent Development

Table 72. Hefei Cosource Pharmacetical Company Information

Table 73. Hefei Cosource Pharmacetical Introduction and Business Overview

Table 74. Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 76. Hefei Cosource Pharmacetical Recent Development

Table 77. Lukang Jituan Saite Yaoye Company Information

Table 78. Lukang Jituan Saite Yaoye Introduction and Business Overview

Table 79. Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 81. Lukang Jituan Saite Yaoye Recent Development

Table 82. Lepu Pharmaceuticals Company Information

Table 83. Lepu Pharmaceuticals Introduction and Business Overview

Table 84. Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 86. Lepu Pharmaceuticals Recent Development

Table 87. Keyuan Pharmaceutical Company Information

Table 88. Keyuan Pharmaceutical Introduction and Business Overview

Table 89. Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product Offerings

Table 91. Keyuan Pharmaceutical Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Isosorbide Mononitrate Sustained-release Tablet Downstream Customers

Table 95. Isosorbide Mononitrate Sustained-release Tablet Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Isosorbide Mononitrate Sustained-release Tablet Product Picture

Figure 2. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume (2019-2030) & (K Units)

Figure 5. Global Isosorbide Mononitrate Sustained-release Tablet Sales Price (2019-2030) & (US$/Unit)

Figure 6. Isosorbide Mononitrate Sustained-release Tablet Report Years Considered

Figure 7. Global Isosorbide Mononitrate Sustained-release Tablet Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Isosorbide Mononitrate Sustained-release Tablet Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Isosorbide Mononitrate Sustained-release Tablet Revenue in 2023

Figure 10. Isosorbide Mononitrate Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 40mg Picture

Figure 12. 50mg Picture

Figure 13. Other Picture

Figure 14. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Isosorbide Mononitrate Sustained-release Tablet Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Clinic

Figure 21. Product Picture of Other

Figure 22. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Isosorbide Mononitrate Sustained-release Tablet Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Isosorbide Mononitrate Sustained-release Tablet Sales Volume (%), (2019-2030)

Figure 39. United States Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 45. China Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 47. China Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 57. India Isosorbide Mononitrate Sustained-release Tablet Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (%), 2023 VS 2030

Figure 59. India Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (%), 2023 VS 2030

Figure 60. Isosorbide Mononitrate Sustained-release Tablet Industrial Chain

Figure 61. Isosorbide Mononitrate Sustained-release Tablet Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions